Phase I Clinical Trial of Autologous Mesothelin Re-directed T Cells in Patients With Chemotherapy Refractory Metastatic Pancreatic Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti mesothelin transduced T cells (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 19 Sep 2017 Biomarkers information updated
- 24 Aug 2013 New trial record